Synchronous multifocal HPV-related neoplasm involving both the genital tract and the head-and-neck area: A case report of Fanconi anemia

Radiotherapy and Oncology

Volumn 92, Issue 1, 2009, Pages 138-141

  Han, Tae Jin ^a   Lee, Chang Hun ^b   Yoo, Chong Woo ^b   Shin, Hye Jin ^b   Park, Hyun Jin ^b   Cho, Kwan Ho ^b   Park, Joo Yong ^b   Choi, Sung Won ^b   Kim, Joo Young ^b  

^a Seoul National University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Fanconi anemia; Genital tract cancer; Head and neck cancer; Human papillomavirus; Radiosensitivity

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER TISSUE; CASE REPORT; CLINICAL FEATURE; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LEUKOPENIA; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTIPLE CANCER; OROPHARYNX CARCINOMA; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VULVA CARCINOMA; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; FANCONI ANEMIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRUS INFECTIONS;

EID: 66949147189     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.03.009     Document Type: Article

References (23)

1. Stanley M.A., Pett M.R., and Coleman N. HPV: from infection to cancer. Biochem Sci 35 (2007) 1456-1460
2. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., and Wacholder S. Human papillomavirus and cervical cancer. Lancet 370 (2007) 890
3. Steenbergen R.D., de Wilde J., Wilting S.M., Brink A.A., Snijders P.J., and Meijer C.J. HPV-mediated transformation of the anogenital tract. J Clin Virol 32 (2005) S25-S33
4. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 467-475
5. González-Bosquet E., Sunol M., Hernandez A., Callejo J., and Lailla J.M. Cancer of the vulva in a 25-year-old woman with VIN III and high-grade cervical SIL - case report. Eur J Gynaecol Oncol 28 (2007) 131-133
6. Pinto K.R., Lu D.W., Rader J.S., and Dávila R.M. Double cervix with bilateral and synchronous HSIL associated with different high-risk HPV types. A case report. Acta Cytol 48 (2004) 273-277
7. McCance D.J., Clarkson P.K., Dyson J.L., Walker P.G., and Singer A. Human papillomavirus types 6 and 16 in multifocal intraepithelial neoplasias of the female lower genital tract. Br J Obstet Gynaecol 92 (1985) 1093-1100
8. Georgieva S., and Iordanov V. A woman with synchronous cervical, vaginal and laryngeal squamous cell carcinomas and positive human papillomavirus type 16; case presentation with literature review. J Balkan Union Oncol 13 (2008) 109-112
9. Gostout B.S., Strome S.E., Clayton A.C., McGovern R.M., Olsen K.D., and Webb M.J. Two cases of coincident carcinomas of the head and neck and the uterine cervix. Gynecol Oncol 85 (2002) 376-380
10. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 97 (2003) 425-440
11. Kutler D.I., Singh B., Satagopan J., et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101 (2003) 1249-1256
12. Kutler D.I., Wreesmann V.B., Goberdhan A., et al. Human Papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 95 (2003) 1718-1721
13. Yamamoto K., Nihrane A., Aglipay J., et al. Upregulated ATM gene expression and activated dna crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis. Mol Med 14 (2008) 167-174
14. Willers H, Kachnic LA, Luo CM, et al. Biomarkers and mechanisms of FANCD2 function. J Biomed Biotechnol 2008;8:821529.
15. Mohseni-Meybodi A., Mozdarani H., and Vosough P. Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation. Cytogenet Genome Res 119 (2007) 191-195
16. Djuzenova C., Flentje M., and Plowman P.N. Radiation response in vitro of fibroblasts from a Fanconi anemia patient with marked clinical radiosensitivity. Strahlenther Onkol 180 (2004) 789-797
17. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8 (2007) 735-748
18. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet 2 (2001) 446-457
19. Taniguchi T., and D'Andrea A.D. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107 (2006) 4223-4233
20. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet 2003 [Chapter 8:Unit 8.7].
21. Kuffel D.G., Lindor N.M., Litzow M.R., Zinsmeister A.R., and Dewald G.W. Mitomycin C chromosome stress test to identify hypersensitivity to bifunctional alkylating agents in patients with Fanconi anemia or aplastic anemia. Mayo Clin Proc 72 (1997) 579-580
22. Spardy N., Duensing A., Charles D., et al. The human Papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. J Virol 81 (2007) 13265-13270
23. Hoskins EE, Morris TA, Higginbotham JM, et al. Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. Nat Oncogene [Epub 2008 Nov 17].